A methamphetamine vaccine attenuates methamphetamine-induced disruptions in thermoregulation and activity in rats
about
Binge-like acquisition of 3,4-methylenedioxypyrovalerone (MDPV) self-administration and wheel activity in ratsStructural characterization of a therapeutic anti-methamphetamine antibody fragment: oligomerization and binding of active metabolitesCurrent approaches for the discovery of drugs that deter substance and drug abuse.Pharmacotherapeutic agents in the treatment of methamphetamine dependence.Intravenous self-administration of entactogen-class stimulants in male ratsLipid tucaresol as an adjuvant for methamphetamine vaccine development.Construction of an enantiopure bivalent nicotine vaccine using synthetic peptides.Vaccines against drugs of abuse: where are we now?Treatment with a monoclonal antibody against methamphetamine and amphetamine reduces maternal and fetal rat brain concentrations in late pregnancy.Treatment of rats with an anti-(+)-methamphetamine monoclonal antibody shortens the duration of action of repeated (+)-methamphetamine challenges over a one month periodAdjuvants for vaccines to drugs of abuse and addiction.Effects of active anti-methamphetamine vaccination on intravenous self-administration in rats.In vivo potency and efficacy of the novel cathinone α-pyrrolidinopentiophenone and 3,4-methylenedioxypyrovalerone: self-administration and locomotor stimulation in male ratsCombining Active Immunization with Monoclonal Antibody Therapy To Facilitate Early Initiation of a Long-Acting Anti-Methamphetamine Antibody ResponseOptimization of a methamphetamine conjugate vaccine for antibody production in miceThe novel recreational drug 3,4-methylenedioxypyrovalerone (MDPV) is a potent psychomotor stimulant: self-administration and locomotor activity in rats.Vaccination protects rats from methamphetamine-induced impairment of behavioral responding for food.Recent advances in the molecular design of synthetic vaccines.Active vaccination attenuates the psychostimulant effects of α-PVP and MDPV in rats.Conjugate Vaccine Immunotherapy for Substance Use Disorder.Biologics to treat substance use disorders: Current status and new directionsLocomotor Stimulant and Rewarding Effects of Inhaling Methamphetamine, MDPV, and Mephedrone via Electronic Cigarette-Type Technology.Inhaled delivery of Δ(9)-tetrahydrocannabinol (THC) to rats by e-cigarette vapor technology.Methamphetamine Vaccines: Improvement through Hapten Design.Current status and future prospects for the development of substance abuse vaccines.Development of a Clinically Viable Heroin Vaccine.Locomotor and reinforcing effects of pentedrone, pentylone and methylone in rats.Effective active vaccination against methamphetamine in female rats.Enhancing Efficacy and Stability of an Antiheroin Vaccine: Examination of Antinociception, Opioid Binding Profile, and Lethality.Altered methamphetamine place conditioning in mice vaccinated with a succinyl-methamphetamine-tetanus-toxoid vaccine.The Main Molecular Mechanisms Underlying Methamphetamine- Induced Neurotoxicity and Implications for Pharmacological Treatment.Improved Admixture Vaccine of Fentanyl and Heroin Hapten Immunoconjugates: Antinociceptive Evaluation of Fentanyl-Contaminated Heroin
P2860
Q27324932-C2238917-DDFA-4851-910D-B6A138B5BA95Q28536667-5CDFEE55-99C3-48E3-A920-FB09CB31D31DQ28973615-786DFAE9-E5A3-4AE9-924A-FEEE5B0EA031Q30235058-EE8066A6-AB21-4A35-900F-3EBB63F9EFB0Q30680394-05D5D9C9-664E-4B7D-9E4A-687881841246Q33662748-A420F948-695D-4351-A03F-822DCE1B9A43Q33751968-2827BB6C-F4C9-44BD-96C2-6BD1FB26D3F1Q33776777-ADF269BE-1833-4468-8AFD-493CD326BA18Q33942970-CF40941B-AB7F-4F90-8731-0D7D537EF6EDQ34602548-415E6547-397D-4478-9A5F-9B775427300DQ35493923-8F23832D-23FE-4DE7-9B47-6B2F0A102F82Q35875875-26D137F6-5B42-4894-AD31-EF07D247C7F2Q35889508-DFCA2A83-0C91-4252-9BFF-7B35853E40CDQ36148294-BA2F61A7-482C-49F7-A285-9BBD56E02597Q36854009-83DC0754-ABC7-474C-86C7-D1FCD21F2ABBQ36926811-1BA5DCA1-8E00-4684-922A-FA2E0B399CCAQ37329852-A4C8A324-8436-42BF-BBE8-0033185F3843Q38639938-5FFF2FD1-096D-45DE-9D32-861EAB82E372Q39107792-F65EC6E4-9591-4380-8162-735919FB0297Q39387013-91BF19A2-408C-460E-AC86-C82B3499B8ECQ39576940-7C94F4AE-2D31-4E78-88F3-8DA6BB06BE34Q39699950-CBAFD29F-A8E8-4B23-8763-1E827F92F9DEQ41654668-5191A875-8F40-4727-93C5-4CE53F334980Q42113438-C16EF320-5433-413E-9679-68F4363D5E52Q43076031-A4212F3D-E118-4594-9C14-1A67F757377CQ45060547-34D69CFB-5FA7-43EE-A835-D8191EA7D7F4Q47647717-3FA2ECB7-7185-400E-B33C-4C94953F6EE4Q47784195-8C2F10D8-E3F9-403C-B930-EE59C5FB62FDQ50113262-0A11E982-941E-4BEF-81E5-3066DEC73FFAQ50548841-C1B1AF7F-4111-499F-BAC0-101CB52E4AEFQ55284097-57595D8E-3E6D-4F6A-9A03-8C566A633EEDQ57063495-2275BA9E-D38A-43D7-A897-BADF6B5D2994
P2860
A methamphetamine vaccine attenuates methamphetamine-induced disruptions in thermoregulation and activity in rats
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
A methamphetamine vaccine atte ...... egulation and activity in rats
@ast
A methamphetamine vaccine atte ...... egulation and activity in rats
@en
type
label
A methamphetamine vaccine atte ...... egulation and activity in rats
@ast
A methamphetamine vaccine atte ...... egulation and activity in rats
@en
prefLabel
A methamphetamine vaccine atte ...... egulation and activity in rats
@ast
A methamphetamine vaccine atte ...... egulation and activity in rats
@en
P2093
P2860
P1476
A methamphetamine vaccine atte ...... egulation and activity in rats
@en
P2093
Amira Y Moreno
Brittani D Vaillancourt
Kevin M Creehan
Kim D Janda
M Jerry Wright
Michael A Taffe
Michelle L Miller
Shawn M Aarde
Sophia A Vandewater
P2860
P304
P356
10.1016/J.BIOPSYCH.2012.09.010
P407
P577
2012-10-23T00:00:00Z